Inventor · disambiguated record
Nicholas Alexander Piers Sascha Buss
Also filed as: BUSS NICHOLAS · BUSS NICHOLAS ALEXANDER PIERS SASCHA · BUSS NICHOLAS ALEXANDER PIERS SASHA
0 granted patents·9 pending applications·0 citations·filing 2019–2025
Top patents by PatentIndex Score
9 records- 0170US2025312492A1Microdystrophin gene therapy administration for treatment of dystrophinopathiesREGENXBIO INC·Filed 2025·Application pending·0 cites
- 0265US2024216543A1Microdystrophin gene therapy administration for treatment of dystrophinopathiesREGENXBIO INC·Filed 2022·Application pending·0 cites
- 0353US2024316217A1Methods for preventing cardiac or skeletal defects in diseases including mucopolysaccharidosesUNIV MINNESOTA·Filed 2022·Application pending·0 cites
- 0452US2025339555A1Formulations for suprachoroidal administration such as formulations with aggregate formationREGENXBIO INC·Filed 2023·Application pending·0 cites
- 0545US2024024508A1Formulations for suprachoroidal administration such as high viscosity formulationsREGENXBIO INC·Filed 2021·Application pending·0 cites
- 0645US2023414788A1Formulations for suprachoroidal administration such as gel formulationsREGENXBIO INC·Filed 2021·Application pending·0 cites
- 0744US2024091380A1Gene therapy for neuronal ceroid lipofuscinosesREGENXBIO INC·Filed 2022·Application pending·0 cites
- 0841US2023364206A1Gene therapy for ocular manifestations of cln2 diseaseREGENXBIO INC·Filed 2021·Application pending·0 cites
- 0939US2021393802A1Gene therapy for neuronal ceroid lipofuscinosesREGENXBIO INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nicholas Alexander Piers Sascha Buss files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →